EuroAsia RND — Research & DevelopmentRNDResearch & Development Enquiry 0

Adavosertib

WEE1 Kinase Inhibitor

CAS
955365-80-7
Formula
C27H32N8O2
Mol. weight
500.61 g/mol
Purity
≥99%

Price on request. CoA, HPLC, NMR and SDS available on request. For Research Use Only. Not for human or veterinary use.

2D structure of Adavosertib
Structure from PubChem CID 24856436

Adavosertib (MK-1775) is an ATP-competitive WEE1 kinase inhibitor that abrogates the G2/M DNA damage checkpoint by preventing inhibitory phosphorylation of CDK1 (Tyr15). This forces checkpoint-deficient cancer cells (commonly p53-mutant) into mitotic catastrophe following DNA damage. Extensively studied in combination with DNA-damaging chemotherapy and PARP inhibitors; active in CCNE1-amplified ovarian cancer.

Target class: DNA damage response (DDR) inhibitors
Research areas: Colorectal Cancer, Lung Cancer, Ovarian Cancer

Related compounds

SMILESCC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O
InChIKeyBKWJAKQVGHWELA-UHFFFAOYSA-N